rhNGF (recombinant human nerve growth factor) with new formulation and antioxidant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rhNGF (recombinant human nerve growth factor) with new formulation and antioxidant, covering 2019-06-14 to 2019-06-14. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 NK [Phase 2]